BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6318079)

  • 1. Glucocorticoid regulation of transcription at an amplified, episomal promoter.
    Ostrowski MC; Richard-Foy H; Wolford RG; Berard DS; Hager GL
    Mol Cell Biol; 1983 Nov; 3(11):2045-57. PubMed ID: 6318079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal response region in the mouse mammary tumor virus long terminal repeat can be dissociated from the proviral promoter and has enhancer properties.
    Ponta H; Kennedy N; Skroch P; Hynes NE; Groner B
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1020-4. PubMed ID: 2983325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of enhancer activity by the hormone responsive regulatory element from mouse mammary tumor virus.
    Ostrowski MC; Huang AL; Kessel M; Wolford RG; Hager GL
    EMBO J; 1984 Aug; 3(8):1891-9. PubMed ID: 6090130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific deactivation of the mouse mammary tumor virus long terminal repeat promoter upon continuous hormone treatment.
    Boronat S; Richard-Foy H; Piña B
    J Biol Chem; 1997 Aug; 272(35):21803-10. PubMed ID: 9268310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDP binding to multiple sites in the mouse mammary tumor virus long terminal repeat suppresses basal and glucocorticoid-induced transcription.
    Zhu Q; Dudley JP
    J Virol; 2002 Mar; 76(5):2168-79. PubMed ID: 11836394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire a selective advantage in lymphocytes by alteration in the U3 region of the long terminal repeat.
    Yanagawa S; Murakami A; Tanaka H
    J Virol; 1990 Jun; 64(6):2474-83. PubMed ID: 2159524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat.
    Overhauser J; Fan H
    J Virol; 1985 Apr; 54(1):133-44. PubMed ID: 2983110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical state, expression and regulation of two glucocorticoid-controlled genes on bovine papilloma virus vectors.
    Matthias P; Boeger U; Danesch U; Schütz G; Bernard HU
    J Mol Biol; 1986 Feb; 187(4):557-68. PubMed ID: 3012094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat.
    Bramblett D; Hsu CL; Lozano M; Earnest K; Fabritius C; Dudley J
    J Virol; 1995 Dec; 69(12):7868-76. PubMed ID: 7494299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular factors binding to a novel cis-acting element mediate steroid hormone responsiveness of mouse mammary tumor virus promoter.
    Lee KI; Reddy EP; Reddy CD
    J Biol Chem; 1995 Oct; 270(41):24502-8. PubMed ID: 7592667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids.
    Härtig E; Cato AC
    Cell Mol Biol Res; 1994; 40(7-8):643-52. PubMed ID: 7787882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat.
    Hsu CL; Fabritius C; Dudley J
    J Virol; 1988 Dec; 62(12):4644-52. PubMed ID: 2846876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subfragments of the large terminal repeat cause glucocorticoid-responsive expression of mouse mammary tumor virus and of an adjacent gene.
    Hynes N; van Ooyen AJ; Kennedy N; Herrlich P; Ponta H; Groner B
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3637-41. PubMed ID: 6304728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of chromatin structure in transcriptional regulation of MMTV LTR hormone-dependent promoter.
    Richard-Foy H; Adom J; Carr K; Gouilleux F; Marsaud V; Redeuilh G; Sabbah M; Sola B
    Rev Esp Fisiol; 1990 Mar; 46(1):31-7. PubMed ID: 2168572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delimitation of a DNA sequence which confers inducibility by glucocorticoid hormones.
    Groner B; Herrlich P; Kennedy N; Ponta H; Rahmsdorf U; Hynes NE
    J Cell Biochem; 1982; 20(4):349-57. PubMed ID: 6306020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mouse mammary tumor virus model in studies of glucocorticoid regulation.
    Hager GL; Richard-Foy H; Kessel M; Wheeler D; Lichtler AC; Ostrowski MC
    Recent Prog Horm Res; 1984; 40():121-42. PubMed ID: 6091192
    [No Abstract]   [Full Text] [Related]  

  • 17. Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter.
    Gouilleux F; Sola B; Couette B; Richard-Foy H
    Nucleic Acids Res; 1991 Apr; 19(7):1563-9. PubMed ID: 1851294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR.
    Jaggi R; Salmons B; Muellener D; Groner B
    EMBO J; 1986 Oct; 5(10):2609-16. PubMed ID: 3023051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription of integrated MMTV LTR DNA in fibroblast clones is not associated with DNA methylation but with the integration site.
    Devaux B; Lefrançois D; Crépin M
    Biochimie; 1985; 67(7-8):853-60. PubMed ID: 3002496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the TATA box in transcription of the mouse mammary tumor virus long terminal repeat.
    Kusk P; Carlson KE; Warren BS; Hager GL
    Mol Endocrinol; 1995 Sep; 9(9):1180-92. PubMed ID: 7491110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.